Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NFE2 |
| Upstream (Parents) |
|---|
| (<<) HMGA2 → NFE2 |
| (<<) HOXD11 → NFE2 |
| (<<) RUNX1 → NFE2 |
| (<<) AEBP1 → NFE2 |
| (<<) TFAP2B → NFE2 |
| (<<) SRY → NFE2 |
| (<<) TBX4 → NFE2 |
| (<<) TSC22D4 → NFE2 |
| (<<) ZNF444 → NFE2 |
| (<<) NR3C2 → NFE2 |
| (<<) ARID3A → NFE2 |
| (<<) NKX3-1 → NFE2 |
| (<<) ELF4 → NFE2 |
| (<<) BATF → NFE2 |
| (<<) ERG → NFE2 |
| Downstream (Children) |
|---|
| NFE2 → ZNF80 (>>) |
| NFE2 → SCAND2 (>>) |
| NFE2 → ALX1 (>>) |
